Dare Bioscience Inc at H C Wainwright BioConnect Conference (Virtual) Transcript
Good morning, everybody. This is Doug Tsao from -- senior analyst at H.C. Wainwright. Thank you, everybody, for joining us for the BioConnect Conference. We are thrilled to have Sabrina Johnson, the CEO of Daré Biosciences (sic) [Daré Biosciences] with us today to talk about the company. So with that, why don't we jump right in because we don't have a ton of time. So Sabrina, you're a company -- or Daré is a company that came to the public markets through a reverse merger. And so I think there is still many investors who aren't familiar with the company's story. So maybe as a starting point, it's always good -- helpful to sort of orient people and provide just an introduction of what Daré is all about and...
© -
Great. Great. Happy to. So thank you, first of all, for the opportunity and for this format. It's a great format. So in terms of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |